Atlas Trials

Rituximab Maintenance Treatment of Newly Diagnosed Follicular Lymphoma After BR or RCHOP or R2: a Multicenter Clinical Study

Clinical trial NCT04842318 · UNKNOWN

Trial details

NCT number
NCT04842318
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Follicular Lymphoma
Start date
2021-03-01
Primary completion
2023-03-01
Enrollment
789

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.